December 8, 2025BloodOpen Access

Machine learning uncovers prognostically distinct myeloma cast nephropathy phenotypes not captured by standard risk stratification systems

View Full Paper

Ask AI

Bookmark

Authors

MHMichael Sang Hughes ALAndrew F. Laine SLSuzanne Lentzsch

Discussion

Member takes

Overview

Unsupervised machine learning reveals two distinct myeloma cast nephropathy phenotypes, highlighting limitations of current risk stratification systems for better survival outcomes.

Key Points

Distinct myeloma cast nephropathy phenotypes were identified using machine learning techniques, enhancing prognostic insights.
The unsupervised machine learning approach involved dimensionality reduction and k-means clustering of patient data, showing clear phenotype differences.
Results demonstrated that the 'high risk' MCN phenotype had inferior overall survival compared to control-like phenotypes among newly diagnosed patients.
This analysis emphasizes the potential of machine learning in revealing treatment-relevant heterogeneity in myeloma cast nephropathy.

Cite This Study

Hughes et al. (2025) studied this question.

synapsesocial.com/papers/69362f6c4fa91c937236e020 https://doi.org/10.1182/blood-2025-5756

View Full Paper

Ask AI

Bookmark

December 8, 2025BloodOpen Access

Machine learning uncovers prognostically distinct myeloma cast nephropathy phenotypes not captured by standard risk stratification systems

View Full Paper

Ask AI

Bookmark

Authors

MHMichael Sang Hughes ALAndrew F. Laine SLSuzanne Lentzsch

Discussion

Member takes

Overview

Unsupervised machine learning reveals two distinct myeloma cast nephropathy phenotypes, highlighting limitations of current risk stratification systems for better survival outcomes.

Key Points

Distinct myeloma cast nephropathy phenotypes were identified using machine learning techniques, enhancing prognostic insights.
The unsupervised machine learning approach involved dimensionality reduction and k-means clustering of patient data, showing clear phenotype differences.
Results demonstrated that the 'high risk' MCN phenotype had inferior overall survival compared to control-like phenotypes among newly diagnosed patients.
This analysis emphasizes the potential of machine learning in revealing treatment-relevant heterogeneity in myeloma cast nephropathy.

Cite This Study

Hughes et al. (2025) studied this question.

synapsesocial.com/papers/69362f6c4fa91c937236e020 https://doi.org/10.1182/blood-2025-5756

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark